Global Prophylactic Human Vaccine Market Competitive Landscape

Amol

posted on 3 years ago — updated on 1 second ago

267
views

Prophylactic Human Vaccine Market

Because of the enormous number of government research funds, North America is likely to lead the worldwide prophylactic human vaccination market. For example, the U.S. Army Medical Research Acquisition Activity awarded GeoVax Labs, Inc., a U.S.-based company, a grant of $2,442,307 in September 2018. The grant was given as part of a cooperative agreement for the development of a novel Lassa Fever (LF) vaccine (GEO-LM01). GEO-LM01 employs a vaccine platform based on Modified Vaccinia Ankara (MVA) and Virus-Like Particle (VLP) that has been shown to be safe and generate antibody responses in patients.

https://knackersblogger.blogspot.com/2022/09/prophylactic-human-vaccine-market-size.html

Amol

Working in Coherent Market Insights. Coherent Market Insights is a global market intelligence and consulting organization, focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan.